Application 215336
- Type
- ANDA
- Sponsor
- AMNEAL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEUPROLIDE ACETATE | LEUPROLIDE ACETATE | INJECTABLE;INJECTION | 1MG/0.2ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A215336-001 | LEUPROLIDE ACETATE | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2022-10-28 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A215336-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A215336-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2022-10-28 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A215336-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2022-10-28 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A215336-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2022-10-28 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A215336-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2022-10-28 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A215336-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2022-10-28 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215336-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2022-10-28 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A215336-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2022-10-28 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215336-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2022-10-28 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215336-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2022-10-28 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215336-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2022-10-28 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215336-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2022-10-28 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215336-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2022-10-28 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215336-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2022-10-28 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A215336-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2022-10-28 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215336-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2022-10-28 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215336-001 | LEUPROLIDE ACETATE | 1MG/0.2ML | INJECTABLE / INJECTION | AP | 2022-10-28 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A215336-001 | LEUPROLIDE ACETATE | 1MG/0.2ML | INJECTABLE / INJECTION | AP | 2022-10-28 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A215336-001 | LEUPROLIDE ACETATE | 1MG/0.2ML | INJECTABLE / INJECTION | AP | 2022-10-28 | 8072bd15b7f6… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A215336-001 | LEUPROLIDE ACETATE | 1MG/0.2ML | INJECTABLE / INJECTION | AP | 2022-10-28 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A215336-001 | LEUPROLIDE ACETATE | 1MG/0.2ML | INJECTABLE / INJECTION | AP | 2022-10-28 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A215336-001 | LEUPROLIDE ACETATE | 1MG/0.2ML | INJECTABLE / INJECTION | AP | 2022-10-28 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A215336-001 | LEUPROLIDE ACETATE | 1MG/0.2ML | INJECTABLE / INJECTION | AP | 2022-10-28 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A215336-001 | LEUPROLIDE ACETATE | 1MG/0.2ML | INJECTABLE / INJECTION | AP | 2022-10-28 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A215336-001 | LEUPROLIDE ACETATE | 1MG/0.2ML | INJECTABLE / INJECTION | AP | 2022-10-28 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A215336-001 | LEUPROLIDE ACETATE | 1MG/0.2ML | INJECTABLE / INJECTION | AP | 2022-10-28 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A215336-001 | LEUPROLIDE ACETATE | 1MG/0.2ML | INJECTABLE / INJECTION | AP | 2022-10-28 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A215336-001 | LEUPROLIDE ACETATE | 1MG/0.2ML | INJECTABLE / INJECTION | AP | 2022-10-28 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A215336-001 | LEUPROLIDE ACETATE | 1MG/0.2ML | INJECTABLE / INJECTION | AP | 2022-10-28 | 3a93d1ddd44b… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A215336-001 | LEUPROLIDE ACETATE | 14MG/2.8ML (1MG/0.2ML) | SOLUTION / SUBCUTANEOUS | AP | 2022-10-28 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A215336-001 | AP | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A215336-001 | AP | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A215336-001 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A215336-001 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A215336-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215336-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A215336-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215336-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215336-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215336-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215336-001 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215336-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215336-001 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A215336-001 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215336-001 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215336-001 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A215336-001 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A215336-001 | AP | 1 | 8072bd15b7f6… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A215336-001 | AP | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A215336-001 | AP | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A215336-001 | AP | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A215336-001 | AP | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A215336-001 | AP | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A215336-001 | AP | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A215336-001 | AP | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A215336-001 | AP | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A215336-001 | AP | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A215336-001 | AP | 1 | 3a93d1ddd44b… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A215336-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LEUPROLIDE ACETATE | LEUPROLIDE ACETATE | Zydus Pharmaceuticals USA Inc. | 35634415-000f-47db-9bd7-9e16eef3f02e | 2026-05-25 | Warnings, Adverse reactions | LEUPROLIDE ACETATE LEUPROLIDE ACETATE |
| Leuprolide Acetate | LEUPROLIDE ACETATE | Sandoz Inc | 8bd72c1e-2751-4498-a346-bc5e3acbba0b | 2026-05-19 | Warnings, Adverse reactions | Leuprolide Acetate LEUPROLIDE ACETATE |
| LEUPROLIDE ACETATE | LEUPROLIDE ACETATE | Eugia US LLC | 49a1d0c1-304c-46f2-a780-bd940ae1ced0 | 2026-05-08 | Warnings, Adverse reactions | LEUPROLIDE ACETATE LEUPROLIDE ACETATE |
| Vabrinty | LEUPROLIDE ACETATE | URONOVA PHARMACEUTICALS, INC. | 008776cc-83f1-4f8c-819b-6471425da15f | 2026-04-30 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| Eligard | LEUPROLIDE ACETATE | TOLMAR Inc. | b7b679a9-6823-4ef8-8d31-3ab5058ffcfc | 2026-04-30 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| leuprolide acetate | LEUPROLIDE ACETATE | Sun Pharmaceutical Industries, Inc. | a3b01473-30c7-4945-bd60-2484221aaaad | 2026-04-24 | Warnings, Adverse reactions | leuprolide acetate LEUPROLIDE ACETATE |
| Leuprolide Acetate | LEUPROLIDE ACETATE | Meitheal Pharmaceuticals Inc | d6bd26bd-b8d8-4c5a-bc5c-7b8a1efaa584 | 2026-04-23 | Warnings, Adverse reactions | Leuprolide Acetate LEUPROLIDE ACETATE |
| leuprolide acetate | LEUPROLIDE ACETATE | UBI Pharma Inc. | cd46628f-055f-4da9-8c38-fa69af34eb4d | 2026-03-29 | Warnings, Adverse reactions | leuprolide acetate LEUPROLIDE ACETATE |
| Lupron Depot | LEUPROLIDE ACETATE | AbbVie Inc. | cbc8f94e-7330-4465-05ad-16d64493a5dd | 2026-03-15 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| LEUPROLIDE ACETATE | LEUPROLIDE ACETATE | Zydus Lifesciences Limited | 4bae0e2a-dd36-4987-85ee-36a52e642ec7 | 2026-02-09 | Warnings, Adverse reactions | LEUPROLIDE ACETATE LEUPROLIDE ACETATE |
| leuprolide acetate | LEUPROLIDE ACETATE | PAI Holdings, LLC dba PAI Pharma | 19be0b7f-e68a-4547-9e49-b51b12821907 | 2026-01-16 | Warnings, Adverse reactions | leuprolide acetate LEUPROLIDE ACETATE |
| Leuprolide Acetate | LEUPROLIDE ACETATE | VGYAAN Pharmaceuticals LLC | bec9077a-3f04-4887-856d-dde2de24584d | 2025-11-21 | Warnings, Adverse reactions | Leuprolide Acetate LEUPROLIDE ACETATE |
| Lupron Depot-PED | LEUPROLIDE ACETATE | AbbVie Inc. | e99f47d2-da10-3127-ecb3-e5d942ae6e81 | 2025-11-14 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| Fensolvi | LEUPROLIDE ACETATE | TOLMAR Inc. | 2c311700-edf4-4f2a-a468-9875489a6cc7 | 2025-09-25 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| Lupron Depot | LEUPROLIDE ACETATE | AbbVie Inc. | 00c486b0-bd7b-4898-834d-8c656e5e73cb | 2025-09-18 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| Lupron Depot | LEUPROLIDE ACETATE | AbbVie Inc. | 60aad237-e1da-4705-cbbb-b3ca79e89ad8 | 2025-09-10 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| Leuprolide Acetate | LEUPROLIDE ACETATE | NorthStar RxLLC | 0cf31b40-816b-d055-e063-6294a90af5d0 | 2025-06-24 | Warnings, Adverse reactions | Leuprolide Acetate LEUPROLIDE ACETATE |
| LUTRATE DEPOT | LEUPROLIDE ACETATE | Avyxa Pharma, LLC | 3a6d1373-17d9-4289-b62f-d299ffe55831 | 2025-06-03 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| LEUPROLIDE ACETATE DEPOT | LEUPROLIDE ACETATE | CIPLA USA INC. | 1563a30b-66e0-445d-ba3e-1ccd5218133f | 2024-08-27 | Warnings, Adverse reactions | LEUPROLIDE ACETATE |
| LEUPROLIDE ACETATE | LEUPROLIDE ACETATE | Endo USA, Inc. | 290b0716-2fd5-43a1-8d3c-4857c1b2eefa | 2024-06-10 | Warnings, Adverse reactions | LEUPROLIDE ACETATE LEUPROLIDE ACETATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 70121-2537 | leuprolide acetate | leuprolide acetate | Amneal Pharmaceuticals LLC | ANDA | Current |